Onyx to acquire Proteolix

Onyx Pharmaceuticals Inc. (NASDAQ:ONXX) will acquire fellow cancer company Proteolix Inc. (South San Francisco, Calif.) for $276 million in cash up front and up to $575 million in potential milestones...